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ABSTRACT
Introduction: Objective measurements of levels of physical activity and fitness in patients with head
and neck cancer (HNC) are lacking. Furthermore, demographic, clinical and lifestyle-related correlates
of low levels of physical activity and fitness in patients with HNC are unknown. This study aims to
investigate the levels of accelerometer that assessed physical activity and fitness in patients with HNC
and to identify their demographical, clinical and lifestyle-related correlates.
Methods: Two hundred and fifty-four patients who were recently diagnosed with HNC and participated
in the NETherlands QUality of life and Biomedical cohort studies In head and neck Cancer (NET-QUBIC)
study were included. Physical activity (accelerometer), cardiorespiratory fitness (Chester Step Test), hand
grip strength (hand dynamometer) and lower body muscle function (30-second chair-stand test) were
assessed. Multivariable linear regression analyses with a stepwise forward selection procedure were used.
Results: Patients spent 229min/d in physical activity of which 18min/d in moderate-to-vigorous physical
activity. The mean predicted VO2max was 27.9ml/kg/min, the mean hand grip strength was 38.1 kg and
the mean number of standings was 14.3. Patients with lower educational level, more comorbidity and
higher tumor stage spent significantly less time in physical activity. Older patients, females and patients
with a higher tumor stage had significantly lower cardiorespiratory fitness levels. Older patients, females,
patients with more comorbidity, patients with normal weight and patients who have never smoked had
significantly lower hand grip strength. Older patients, patients with lower educational level, smokers and
patients with more comorbidity had a significantly lower function of lower body muscle.
Conclusions: Pre-treatment levels of physical activity, cardiorespiratory fitness and lower body muscle
function are low in patients with HNC. Based on this study, exercise programs targeted and tailored to
patients with low levels of physical activity and fitness can be developed.
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Introduction
Head and neck cancer (HNC) comprises different sites of can-
cer in the head and neck region and accounts for more than
650,000 cases and 330,000 deaths annually [1]. Smoking,
alcohol consumption and infection with the human papillo-
mavirus (HPV) are the most common risk factors for develop-
ing HNC [2]. Observational studies showed that higher levels
of physical activity following the diagnosis and treatment of
cancer and higher levels of physical fitness before the diag-
nosis of cancer are associated with reduced mortality [2–4]
and better quality of life [5], but the relationship is not uni-
form, may differ by the type of cancer. Based on these stud-
ies, it seems clear that levels of physical activity and fitness
play an important role in the risk of cancer, the quality of life
of patients with cancer and mortality in patients with cancer.
Physical activity is a behavior that includes occupational,
leisure, household or other activities, whereas health-related
physical fitness is a set of attributes that people have or
achieve and which includes cardiorespiratory fitness and
muscle strength [6]. Previous retrospective studies showed
that 31% of patients with HNC met the current physical
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activity guideline pre-diagnosis, which decreased to 8.5%
after diagnosis [7] and declines further during treatment
[5,8,9]. However, all these studies measured physical activity
through self-report, which is prone to bias [10] and likely to
over- or underreport physical activity levels [11].
Unfortunately, objective measurements of physical activity
levels in patients with HNC are lacking and physical fitness
levels have only been investigated previously in small groups
of patients with HNC participating in pilot exercise interven-
tion studies [12,13]. Therefore, objective measurements of
levels of physical activity and fitness in a large group of
patients with HNC are warranted.
Identifying physically inactive and unfit patients with HNC
before the start of treatment is important to timely refer
patients to exercise programs because it may lead to an
improvement in physical function [12], fatigue [12,14] and
quality of life [12]. To target and tailor these exercise pro-
grams to subgroups of patients with low levels of physical
activity and fitness, it may help to identify their demo-
graphic, clinical and lifestyle-related correlates.
Therefore, we aimed to investigate the levels of acceler-
ometer that assessed physical activity and fitness in a large
sample of patients with HNC shortly after diagnosis, and to
identify the demographic, clinical and lifestyle-related corre-
lates of physical activity and fitness.
Methods
Study design
The current study has a cross-sectional design in which data
from participants of the NETherlands QUality of life and
Biomedical cohort studies In head and neck Cancer (NET-
QUBIC) study was used [15]. The NET-QUBIC study is a longi-
tudinal observational cohort study in 739 newly diagnosed
patients with HNC. The research protocol was reviewed and
approved by the Medical Ethics Committee of VU University
Medical Center and all Boards of participating medical cen-
ters. All patients provided written informed consent prior to
participation.
Study population
In the current study, we used baseline data from the first
254 patients who were included between February 2014 and
June 2016 from eight HNC centers throughout the
Netherlands. The data release of the first 254 patients was
pre-planned and in the current cross-sectional study these
data was used [15]. Baseline assessments took place shortly
after the diagnosis of HNC and before the start of treatment.
To be eligible for the NET-QUBIC study, patients needed to
be (i) diagnosed with HNC (oral cavity, oropharynx, hypo-
pharynx, larynx, unknown primary; all stages), (ii) before start
of treatment and (iii) able to read, speak and write the Dutch
language. Patients were excluded if they (i) had malignancies
of the salivary glands, nasopharyngeal malignancies, lymph-
oma, skin malignancies or thyroid cancer or (ii) had
psychiatric comorbidities (e.g., schizophrenia, Korsakoff’s syn-
drome, severe dementia).
Main outcomes
The total NET-QUBIC assessment protocol involved three
components: (1) patient reported outcome measures, (2)
home visit with interviews and tests (including physical fit-
ness); during this home visit patients were provided with
materials to collect data of physical activity (accelerometer)
and saliva samples and (3) collection of blood and oral rinse
samples. Due to logistic reasons not all components could
always be performed (e.g., short time between diagnosis and
start of treatment). Also, patients were allowed not to com-
plete all three components, if this was too much burden.
Accelerometer assessed physical activity
Patients were instructed to wear an accelerometer (ActiGraph
wGT3X) at the hip for seven consecutive days during all wak-
ing hours. The accelerometer measures raw accelerations in
three axes and is recognized as a reliable and valid tool to
assess physical activity in healthy persons [16]. Vertical acceler-
ations were converted into physical activity using several data
reduction steps [17]. A valid wear day was defined as
10hours/day of wearing time and non-wearing time as
60min of consecutive zero counts [17]. To be included in
the analyses, the number of valid wear days needed to be at
least five, including one weekend day. Time spent in total
physical activity was expressed as the mean number of
minutes in any intensity of physical activity per day (100
counts per minute). Moderate-to-vigorous physical activity
(MVPA) was defined as 1952 counts per minute [17].
Physical fitness
The Chester Step Test was used to predict the maximum
oxygen uptake (predicted VO2max). It has shown to be a
valid test for the estimation of aerobic capacity in healthy
participants and is suitable for use in the patient’s home
environment [18]. Participants were instructed to step up
and down a single step (height between 15 and 30 cm,
depending on age and physical capacity of the patient) to a
metronome beat at 60 steps per minute for 2min, after
which both heart rate and rating of perceived exertion (RPE)
ranging from 6 (very light) to 20 (exhaustion) were recorded
[19]. Step rate then increased by 20 steps/min every next
2min where after heart rate and RPE were recorded again.
The test followed this incremental pattern until patients
either reached: (i) a heart rate of 80% of the predicted max-
imum (220 – age), (ii) an RPE of 14 or (iii) completed the
test, i.e., five stages (last stage: 136 steps per minute). Heart
rates after completion of each stage were plotted on a
graphical datasheet and a visual line of best-fit was drawn
between the measured heart rates. This line was extended
until it reached the 80% of the maximum heart rate of that
patient, which was calculated by subtracting the patient’s
age from 220. The point where the drawn line and the 80%
maximum heart rate line crossed each other, determined
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the matching maximal oxygen uptake value. At least two
valid heart rate measurements were needed to estimate the
maximal oxygen uptake.
Handgrip strength was assessed with a hand grip dyna-
mometer (JAMAR), which has shown to be a valid assess-
ment of upper extremity strength [20]. Participants were
instructed to perform a maximal isometric contraction and to
complete two consecutive measurements for each hand. The
highest value of the four attempts was used as indicator for
hand grip strength.
Lower body muscle function was assessed using the func-
tional 30-second chair-stand test, which has shown to be a
reliable and valid indicator of lower body function [21].
Participants were instructed to rise to a full stand and return
to the original seated position as quickly as possible. The
total number of times that the participants raised to a full
stand in 30 seconds was reported.
Demographic factors
Educational level and living status were assessed with an
interview or through questionnaires. Any educational level
equal or lower than ‘lower or preparatory vocational educa-
tion’ was defined as a low level of education. Living status
was dichotomized into living with someone (e.g., partner,
(grand)child) versus living alone.
Clinical factors
Body height and weight were assessed during a home visit
at the patient’s home and body mass index (BMI) was calcu-
lated (body weight/height2, kg/m2). A BMI between 18.5 and
25 kg/m2 was defined as normal weight, a BMI below
18.5 kg/m2 as underweight, a BMI above 25 kg/m2 as over-
weight and a BMI above 30 kg/m2 as obesity. Primary tumor
site, tumor stage and human papilloma virus (HPV) status
were retrieved from medical records. Based on clinical rele-
vance, tumor stage was dichotomized into stage I–III versus
stage IV. Comorbidity was assessed with the Adult
Comorbidity Evaluation-27 (ACE-27) based on data retrieved
from the medical record, resulting in an overall score of
none, mild, moderate or severe [22]. Subsequently, this over-
all comorbidity score was dichotomized into none/mild ver-
sus moderate/severe.
Lifestyle-related factors
Smoking habits and alcohol consumption were assessed with
a study-specific questionnaire. Patients who had never
smoked or drank alcohol on a daily basis were labeled as
having no history of smoking or alcohol consumption,
respectively. Patients who had previously smoked or drank
alcohol but did not smoke or drank alcohol currently were
labeled as having a history of smoking or alcohol consump-
tion, respectively. All patients who smoked or consumed
alcohol on a daily basis, were labeled as smokers and con-
sumers of alcohol, respectively.
Statistical analyses
Linear regression analyses were conducted to identify varia-
bles that were significantly associated with total time spent
in physical activity, cardiorespiratory fitness, hand grip
strength and lower body muscle function, with separate
models for each continuous outcome measure. Prior to the
multivariable analyses, we checked whether multicollinearity
(r 0.60) was present between the potential correlates, but
this was not the case. Furthermore, assumptions of linear
regression analyses were checked and met. A stepwise
Table 1. Demographic, clinical and lifestyle related characteristics and physical
activity and fitness of patients with at least one valid measurement of phys-
ical activity or fitness (n¼ 216).
Characteristics Total group
Age, mean (SD) years 62 (9.8)
Gender, male, n (%) 162 (75)
BMI, n (%)
Underweight 11 (5)
Normal weight 91 (42)
Overweight 79 (37)
Obesity 32 (15)
Unknown 3 (1)
Level of education, n (%)
Low level 65 (30)
Intermediate/high level 148 (69)
Unknown 3 (1)
Alcohol consumption, n (%)
Never 19 (9)
Yes 135 (63)
Former 28 (13)
Unknown 34 (16)
Smoking, n (%)
Never 26 (12)
Yes 57 (26)
Former smoker 101 (47)
Unknown 32 (15)
Tumor site, n (%)
Oral cavity 60 (28)
Oropharynx – HPV positive 38 (18)
Oropharynx – HPV negative 29 (13)
Oropharynx – HPV unknown 8 (4)
Hypopharynx 20 (9)
Larynx 57 (26)
Unknown primary 4 (2)
Tumor stage, n (%)
Stage I, II or III 127 (59)
Stage IV 89 (41)
Comorbidity, n (%)
None/mild 134 (62)
Moderate/severe 69 (32)
Unknown 13 (6)
Living status, n (%)
Alone 52 (24)
With partner/child 162 (75)
Unknown 2 (1)
Wear time accelerometera, mean minutes/day (SD) 859.0 (98.0)
Total physical activitya, mean minutes/day (SD) 229.4 (83.4)
Moderate to vigorous activitya, mean minutes/day (SD) 17.9 (16.1)
Cardiorespiratory fitnessb, predicted VO2max in ml/kg/min (SD) 27.9 (10.9)
Womenc, predicted VO2max in ml/kg/min (SD) 25.0 (7.1)
Mend, predicted VO2max in ml/kg/min (SD) 28.7 (11.6)
Hand grip strengthe, kg (SD) 38.1 (10.8)
Womenf, kg (SD) 26.8 (6.3)
Meng, kg (SD) 41.9 (9.2)
Lower body muscle functionh, times standing
during 30 s chair-stand test (SD)
14.3 (4.6)
SD: standard deviation; n: number; BMI: body mass index; HPV: human
papilloma virus.
an-103; bn-71; cn¼ 31; dn¼ 93; en-3; fn¼ 54; gn¼ 159; hn-17.
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forward selection procedure was used to build the multivari-
able regression models, starting with the variable that was
most strongly associated with the outcome in the univariable
regression model. Subsequently, the next strongest variable
was selected after controlling for the first variable. This pro-
cedure was repeated until no variables with an association
with the outcome at a significance level of p<.10 could be
added to the model. We used a significance level of <0.10
to avoid missing important correlates when building the
model [23]. The regression coefficients (b) with 95% confi-
dence interval (CI) and corresponding p values of the final
models were reported. The regression coefficients reflect the
absolute difference between the two categories of a variable.
As levels of cardiorespiratory fitness [24] and hand grip
strength [25] differ between males and females, we per-
formed a sensitivity analysis studying correlates for these
outcomes separately for men and women. To check whether
missing values were selective, we performed logistic regres-
sion analyses to study differences in demographic, clinical
and lifestyle-related characteristics between the patients
with missing values and those without. Due to the high
number of variables, we only included variables in the multi-
variable regression model of which the association with miss-
ings had a p value <.25 in the univariable model. All
analyses were conducted with SPSS version 22 (SPSS Inc.,
Chicago, IL, USA).
Results
In total, 254 patients were included in the NET-QUBIC study
and in 38 patients a home visit was not performed and thus
had no measurements of physical activity and fitness.
Women were more likely to have no data on home visits
[odds ratio (OR)¼0.37, 95%CI 0.18 to 0.75, p<.01].
The mean age of the 216 patients that was included in this
study was 62 years (SD 9.8) and 75% were men (Table 1). The
proportion of patients that completed the measurements of
physical activity, cardiorespiratory fitness, hand grip strength
and lower body muscle function was 52, 65, 99 and 92%,
respectively (Figure 1). Most frequent reasons for incomplete
measurements were: insufficient time left for the accelerom-
eter measurements prior to start of treatment (51%) and mus-
culoskeletal impairments (27% and 47% for the Chester Step
Test and 30-second chair-stand test, respectively) (Figure 1).
Table 2 presents differences between patients with and with-
out missing values for physical activity as this outcome had
the largest proportion of missing values. There were no varia-
bles significantly and independently associated with missing
data on physical activity, nor for hand grip strength and lower
body muscle function (data not shown). Patients with a valid
Chester Step Test were more likely to be younger (OR ¼ 0.92,
95%CI ¼ 0.87 to 0.97, p<.01) and have less comorbidity (OR
¼ 0.31, 95%CI ¼ 0.13 to 0.74, p¼.01) than patients without a
valid Chester Step Test.
Patients spent on average 229min/d in physical activity of
which on average 18min/d in MVPA. The mean predicted
VO2max was 27.9ml/kg/min, the mean hand grip strength
was 38.1 kg, and the mean number of stands was 14.3 times
(Table 1).
Multivariable regression analyses showed that patients
with a lower educational level, a higher level of comorbidity
and a higher tumor stage spent significantly less time in
physical activity (Table 3). Patients with a higher tumor stage
and a higher comorbidity level spent less time in MVPA.
Figure 1. Flowchart.
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Older patients, females and patients with a higher tumor
stage had significantly lower cardiorespiratory fitness levels
(Table 3). Sensitivity analyses stratified for gender did not
yield any other correlates.
Older patients, females, patients with more comorbidity,
patients with a normal weight (compared to patients with
overweight and obesity, patients with no history of smoking
(compared to patients with a history of smoking) and
patients living alone had significant lower hand grip strength
(Table 3). Sensitivity analyses stratified for gender did not
yield any other correlates.
Older patients, patients with a low educational level,
smokers and patients with more comorbidity had a signifi-
cant lower function of the lower body muscle (Table 3).
Discussion
This study investigated the levels and the demographic, clin-
ical and lifestyle-related correlates of accelerometer that
assessed physical activity and fitness in a relatively large
group of newly diagnosed patients with HNC.
Our finding that newly diagnosed patients with HNC
before start of treatment spent on average 229min/d in
physical activity is substantial lower than the 375min found
in healthy persons who were slightly older [26] and the
296–323min in long-term survivors of various types of can-
cer in the same age range [27,28]. Also the 18min/d spent in
MVPA, was lower than 26min reported in one study among
cancer survivors with a mean age of 59 years [28], but was
comparable to the 16min found in another study among
cancer survivors with a mean age of 61 years [27]. A possible
explanation for the lower levels of physical activity and
MVPA in this sample might be the recent diagnosis of cancer
with companying psychosocial impact. Furthermore,
unhealthy lifestyle habits like smoking and alcohol drinking
which are specific for this tumor type tend to cluster with
physical inactivity [29]. The estimated cardiorespiratory fit-
ness level (mean 27.9ml/kg/min) of patients in this study
was lower than the measured VO2max of 33.7ml/kg/min
reported in healthy populations [30], but higher than the
directly measured VO2max of 23.7ml/kg/min in patients
with cancer during or following treatment [31]. However,
previous research has shown that submaximal exercise tests,
especially in participants with low levels of physical fitness,
overestimate the actual measured exercise capacity [32].
Furthermore, patients in this study who completed the
Chester Step Test were significantly younger and had less
comorbidity than patients who did not complete the test.
The mean hand grip strength for women and men in this
study was comparable to the grip strength found in healthy
elderly [33] and in slightly younger patients with different
types of cancer during or after treatment [31]. The 14 times
standing during the 30-second chair-stand test, was slightly
lower than the 17 times reported in patients during or fol-
lowing treatment for different types of cancer [31], which
might be explained by the younger age in the latter study.
Overall, results showed that newly diagnosed patients with
HNC before treatment have lower levels of physical activity,
cardiorespiratory fitness and lower body muscle function
compared with the general population and survivors with
various types of cancer, but comparable hand grip strength.
The low physical activity and fitness levels before the start
of treatment found in this study need further attention,
because, in general, these levels are likely to decrease further
during treatment [7]. An exercise intervention is currently
not part of routine care in patients with HNC, although it
may improve physical function, fatigue and quality of life
[12,34]. However, more research is needed into the feasibility
and effectiveness of exercise interventions targeting HNC
patients before, during and after treatment.
The present study provides correlates of low levels of
physical activity and fitness. Our finding that patients with a
lower educational level were less physically active and had
lower function of the lower body muscle has been shown in
previous studies among patients with breast and colon can-
cer [35,36]. The finding that older patients had lower cardio-
respiratory fitness levels, lower hand grip strength and
Table 2. Demographic, clinical and lifestyle related characteristics of partici-
pants with accelerometer data and without accelerometer data.
Characteristics
No accelerometer
data (n¼ 103)
Accelerometer
data (n¼ 113)
Age, mean (SD) 61.3 (10.5) 62.7 (9.1)
Gender, male, n (%) 78 (76) 84 (74)
BMI, mean (SD) kg/m2 25.5 (4.8) 25.8 (4.5)
BMI category, n (%)
Underweight 5 (5) 6 (5)
Normal weight 48 (47) 43 (38)
Overweight 33 (32) 46 (41)
Obesity 16 (16) 16 (14)
Unknown 1 (1) 2 (2)
Level of education, n (%)
Low level 32 (31) 33 (29)
Intermediate/high level 70 (68) 78 (69)
Unknown 1 (1) 2 (2)
Alcohol consumption, n (%)
Never drinker 9 (9) 10 (9)
Drinker 60 (58) 75 (66)
Former drinker 12 (12) 16 (14)
Unknown 22 (21) 12 (11)
Smoking, n (%)
Never smoker 12 (12) 14 (12)
Smoker 30 (29) 27 (24)
Former smoker 41 (40) 60 (53)
Unknown 20 (19) 12 (11)
Tumor site, n (%)
Oral cavity 37 (36) 23 (20)
Oropharynx HPV positive 10 (10) 28 (25)
Oropharynx HPV negative 14 (14) 15 (13)
Oropharynx HPV status unknown 3 (3) 5 (4)
Hypopharynx 9 (9) 11 (10)
Larynx 27 (26) 30 (27)
Unknown primary 3 (3) 1 (1)
Tumor stage, n (%)
Stage I, II or III 72 (70) 55 (49)
Stage IV 31 (30) 58 (51)
Comorbidity, n (%)
None/mild 58 (56) 76 (67)
Moderate/severe 36 (35) 33 (29)
Unknown 9 (9) 4 (4)
Living status, n (%)
Alone 27 (26) 25 (22)
With partner/child 76 (74) 86 (76)
Unknown 0 (0) 2 (2)
n: number; SD: standard deviation; BMI: body mass index; HPV: human papil-
loma virus.
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reduced lower body muscle function is consistent with previ-
ous studies in patients with other cancer types [37,38]. In
contrast to previous studies among patients with HNC that
used self-reported measures to assess physical activity [39],
we found no significant association between age and phys-
ical activity. This discrepancy might be due to the fact that
low intensity activities, which are typical for elderly, are chal-
lenging to estimate correctly by self-report [40], or by the
reasonable number of patients that did not complete the
accelerometer measurements. These findings indicate that
interventions to improve physical activity and fitness should
be particularly targeted at and tailored to patients with HNC
who are older and have lower educational level, especially
because these patients are less reached with existing inter-
ventions aiming to improve physical activity and fitness [41].
Female gender was associated with lower levels of cardio-
respiratory fitness and lower hand grip strength, which was
in line with earlier studies [37,38]. Furthermore, the positive
association between BMI and hand grip strength, was also in
line with an earlier study [42].
The findings in this study that patients with metastatic
cancer had lower levels of accelerometer that assessed phys-
ical activity and cardiorespiratory fitness are in line with pre-
vious studies, where, for example, breast and kidney cancer
survivors with an early disease stage were more likely to
meet physical activity guidelines than survivors with an
advanced disease stage [43]. Additionally, patients with
metastatic breast cancer had significantly lower levels of car-
diorespiratory fitness than patients with less advanced stages
of disease [44]. Our finding that patients with more comor-
bidity spent less time in physical activity and had lower lev-
els of hand grip strength and lower body muscle function is
in line with the results of previous studies. More comorbidity
and a higher tumor stage might be accompanied by a higher
symptom burden of these patients, which may be associated
with functional impairment and lower levels of physical activ-
ity and fitness [45]. Future exercise interventions should be
optimally tailored to patients with comorbidities and a
higher tumor stage [46].
Surprisingly, a history of smoking was associated with a
higher hand grip strength compared to no history of smok-
ing in this study, while a previous study reported negative
associations between smoking and hand grip strength [47].
A possible explanation might be that (former) smokers were
more involved in manual labor compared with patients who
have never smoked, resulting in higher grip strength [48].
Furthermore, smoking was associated with a reduced lower
body muscle function in this study, which may be related to
reduced skeletal muscle oxidative capacity, blood flow and
strength [49]. On the other hand, we found no significant
association between smoking behavior and cardiorespiratory
fitness [50], which might be due to lower variance among
patients who had completed the Chester Step Test.
Strengths of this study are the large sample size of
patients with HNC all measured before start of treatment
and the use of accelerometers to assess physical activity. The
relatively large number of missing values on physical activity
and/or fitness measurements is a limitation of this study,
which limits generalizability to older patients with more
comorbidities. Due to home-based assessments, we used the
submaximal step test to estimate cardiorespiratory fitness
instead of direct measurements, which may have overesti-
mated levels of physical fitness.
Conclusions
In conclusion, pre-treatment levels of cardiorespiratory fit-
ness, lower body muscle function and time spent in total
and MVPA are low in patients with HNC. A higher age,
female gender, higher tumor stage, lower educational level
and more comorbidity were associated with lower levels of
objective measurements of physical activity and fitness in
patients with HNC. Based on this study, exercise programs
can be particularly targeted and tailored to older, less edu-
cated patients with comorbidities and higher tumor stage,
because these patients are specifically at risk for inactivity
and low fitness levels and often do not participate in an
exercise program [41].
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